Metabolic control during the first two years of the COVID-19 pandemic in pediatric patients with type 1 diabetes: results from the German DPV initiative.
Johanna HammersenSascha R TittelSemik KhodaverdiFelix ReschkeMonika FluryUlrike MenzelKirsten MönkemöllerThomas MeissnerBeate KargesReinhard W HollPublished in: Acta diabetologica (2023)
We found no clinically relevant change of glycemic control or incidence of acute diabetes complications during the pandemic. The observed BMI increase may represent an important health risk for youth with T1D.
Keyphrases
- glycemic control
- health risk
- type diabetes
- risk factors
- liver failure
- heavy metals
- blood glucose
- drinking water
- sars cov
- coronavirus disease
- respiratory failure
- quality improvement
- body mass index
- weight loss
- physical activity
- mental health
- insulin resistance
- young adults
- drug induced
- aortic dissection
- weight gain
- risk assessment
- cardiovascular disease
- metabolic syndrome
- extracorporeal membrane oxygenation
- intensive care unit
- adipose tissue
- acute respiratory distress syndrome